3,4-dihydroxyphenylacetic acid has been researched along with betadex in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnesano, F; Belgiovine, G; Cassano, T; Castellani, S; Cometa, S; Conese, M; De Giglio, E; Di Gioia, S; Lavecchia, MA; Mandracchia, D; Mangini, V; Pace, L; Puglisi, G; Trapani, A; Trapani, G | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and betadex
| Article | Year |
|---|---|
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Intranasal; Animals; beta-Cyclodextrins; Cells, Cultured; Chemistry, Pharmaceutical; Chitosan; Corpus Striatum; Cross-Linking Reagents; Dopamine; Drug Carriers; Drug Stability; Epithelial Cells; Magnetic Resonance Spectroscopy; Male; Microscopy, Fluorescence; Nanomedicine; Nanoparticles; Olfactory Bulb; Olfactory Mucosa; Photoelectron Spectroscopy; Rats, Wistar; Solubility; Technology, Pharmaceutical; Tissue Distribution | 2015 |